Expertise
Chronic Pain: The Other Public Health Crisis  |  February 15, 2019

“We want to make sure that as we deal with the opioid crisis, we keep in mind those Americans who are hurting.” This statement was made by Senate Health Committee Chairman Senator Lamar Alexander during this week’s Health, Education, Labor & Pensions (HELP) Committee Hearing amidst increasing public discussion of the impact of the opioid…

Read More ›
axial takeaway: R in Business  |  February 4, 2019

By Meridith Peratikos, Director of Enterprise Research In January, researchers and technologists across a wide range of disciplines and job sectors converged at the RStudio::conf 2019 in Austin, Texas to celebrate and learn about R, a programming language for statistical computing and graphics, as well as discuss RStudio tools that make using R for business…

Read More ›
axial takeaway: The Importance of Knowing Your Data  |  January 3, 2019

By Lindsey Morris, Ph.D., Director, Data Science and Analytics Sin City beckons tens of thousands of technology leaders from around the world to Amazon Web Service’s (AWS) re:Invent, a quintessential, annual technology conference where AWS reveals it’s cutting-edge technology offerings for the coming year. The advancements are always presented during keynote addresses in a minimalistic yet curiously…

Read More ›
Unpacking the Machine Learning Black Box in Healthcare Applications  |  December 20, 2018

By May Shen, PhD, Research Data Scientist Machine learning models are being quickly adopted in various industry applications because of their outstanding performance compared to more traditional approaches like linear regression. However, machine learning models are also known as ‘black boxes’ because they provide little explanations for their predictions. The black-box nature of many machine learning…

Read More ›
2018 in Review: Impactful Literature on Pain & Opioids  |  December 19, 2018

At axialHealthcare, our pain and opioid care solutions are based in and continually updated with the latest peer-reviewed evidence. In order to maintain the highest standards for our products, and the patient care they support, our experts sort through thousands of publications each year. Adding more than 100 publications to our compendium this year, we’ve…

Read More ›
Medical Cannabis: Therapeutic Utility and Risks  |  December 3, 2018

By Louis J Czaja, PharmD, BCGP, Clinical Pharmacy Specialist As America’s opioid epidemic continues to escalate, the discussion surrounding legalizing medical marijuana has been widely considered as a means to combat it. Currently, marijuana is the most commonly used illicit drug in the United States, with 40 million people 12 years of age or older reporting…

Read More ›